AWA
FLGT icon

Arkadios Wealth Advisors’s Fulgent Genetics FLGT Stock Holding History

Arkadios Wealth Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,743
Closed -$246K – 992
2021
Q3 		$246K Buy
2,743
+115
+4% +$10.5K 0.04% 454
2021
Q2 		$242K Buy
2,628
+977
+59% +$78K 0.03% 489
2021
Q1 		$159K Sell
1,651
-263
-14% -$27.1K 0.03% 443
2020
Q4 		$99K Buy
+1,914
New +$80K 0.02% 441

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Arkadios Wealth Advisors's FLGT Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of Fulgent Genetics (FLGT) in Q4 2021, closing a stake of 2,743 shares — an estimated $246K sold.

Arkadios Wealth Advisors first reported a position in FLGT in Q4 2020 and held it in 4 quarters. The position peaked at $246K in Q3 2021. 299 funds tracked by Wall St. Rank hold FLGT as of Q4 2021.

  • Arkadios Wealth Advisors reported no remaining Fulgent Genetics position as of Q4 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 2,743 Fulgent Genetics shares in Q4 2021, an estimated $246K.
  • Arkadios Wealth Advisors first reported a position in Fulgent Genetics in Q4 2020 and held it in 4 quarters.
  • Arkadios Wealth Advisors's Fulgent Genetics position peaked at $246K in Q3 2021.
  • 299 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.